Prostatis Group’s Vanguard Small-Cap Value ETF VBR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-50,501
Closed -$51.3K 234
2023
Q2
$51.3K Buy
+50,501
New +$7.95M 0.02% 176
2022
Q1
Sell
-2,043
Closed -$365K 105
2021
Q4
$365K Sell
2,043
-774
-27% -$138K 0.22% 62
2021
Q3
$477K Sell
2,817
-77
-3% -$13.2K 0.28% 59
2021
Q2
$503K Sell
2,894
-253
-8% -$43.8K 0.34% 56
2021
Q1
$521K Buy
3,147
+721
+30% +$114K 0.41% 58
2020
Q4
$345K Buy
+2,426
New +$313K 0.29% 62

Other funds holding VBR

Prostatis Group's VBR Position: Q3 2023 in Review

Prostatis Group sold out of Vanguard Small-Cap Value ETF (VBR) in Q3 2023, closing a stake of 50,501 shares — an estimated $51.3K sold.

Prostatis Group first reported a position in VBR in Q4 2020 and held it in 6 quarters. The position peaked at $521K in Q1 2021. 1,233 funds tracked by Wall St. Rank hold VBR as of Q3 2023.

  • Prostatis Group reported no remaining Vanguard Small-Cap Value ETF position as of Q3 2023 after selling out during the quarter.
  • Prostatis Group sold 50,501 Vanguard Small-Cap Value ETF shares in Q3 2023, an estimated $51.3K.
  • Prostatis Group first reported a position in Vanguard Small-Cap Value ETF in Q4 2020 and held it in 6 quarters.
  • Prostatis Group's Vanguard Small-Cap Value ETF position peaked at $521K in Q1 2021.
  • 1,233 funds tracked by Wall St. Rank held Vanguard Small-Cap Value ETF as of Q3 2023.

Based on Prostatis Group's 13F filing for Q3 2023, filed 21 Mar 2025.